MRK Merck & Co.
NYSE · SEC CIK 310158 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $72.01M 21 sales by 11 insiders
- Filings on record
- 398 since 2021-07-02, latest 2026-08-13 17:02
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Zachary Jennifer | EVP, GC | — | $25.20M |
| DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | — | $11.29M |
| Guindo Chirfi | EVP, Access, Policy, Comms | — | $8.15M |
| Williams David Michael | EVP, Chief Info, Digital Off | — | $8.13M |
| Davis Robert M | COB, CEO, Pres, Dir | — | $5.60M |
| Litchfield Caroline | EVP, CFO | — | $5.02M |
| Li Dean Y | Pres, Executive VP, MRL | — | $2.99M |
| Maraldo David R. | EVP, Pres. MMD | — | $2.41M |
| Oosthuizen Johannes Jacobus | Pres, U.S. Market | — | $1.83M |
| Smart Dalton E. III | SVP Fin. - Gbl Ctrl | — | $766.0K |
Transactions 310
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-03 | 2021-11-01 | MRK | Gerberding Julie L. | EVP, Chief Patient Off | S - Sale+OE | $87.91 | -96.3K | 39.2K | -71% | -$8.46M |
| D | 2021-11-02 | 2021-10-30 | MRK | MIZELL STEVEN | EVP, Chief HR Off | F - Tax | $88.05 | -2,323 | 25.6K | -8% | -$204.5K |
| D | 2021-11-02 | 2021-10-30 | MRK | MIZELL STEVEN | EVP, Chief HR Off | M - OptEx | $88.05 | +4,715 | 27.9K | +20% | +$415.2K |
| D | 2021-11-02 | 2021-10-29 | MRK | Chattopadhyay Sanat | Exe V-P, Pres. MMD | S - Sale+OE | $87.32 | -24.6K | 93.1K | -21% | -$2.15M |
| D | 2021-11-02 | 2021-10-29 | MRK | Chattopadhyay Sanat | Exe V-P, Pres. MMD | M - OptEx | $0.00 | +24.6K | 117.8K | +26% | $0 |
| DM | 2021-11-02 | 2021-10-30+ | MRK | Clyburn Frank | EVP, Pres ? Human Health | M - OptEx | $4.93 | +42.1K | 136.9K | +44% | +$207.6K |
| D | 2021-11-02 | 2021-10-30 | MRK | Clyburn Frank | EVP, Pres ? Human Health | F - Tax | $88.05 | -1,162 | 97.1K | -1% | -$102.3K |
| D | 2021-11-02 | 2021-11-01 | MRK | Clyburn Frank | EVP, Pres ? Human Health | S - Sale+OE | $87.87 | -39.8K | 97.1K | -29% | -$3.49M |
| DM | 2021-11-02 | 2021-10-29 | MRK | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | M - OptEx | $0.00 | +135.4K | 190.0K | +248% | $0 |
| D | 2021-11-02 | 2021-10-29 | MRK | DeLuca Richard R. | EVP, Pres, Merck Animal Heallth | S - Sale+OE | $87.56 | -135.4K | 116.9K | -54% | -$11.86M |
Purchase Sale Sale after option exercise All abbreviations